4.6 Article

Extended thromboprophylaxis post gynaecological cancer surgery; the effect of weight adjusted and fixed dose LMWH (Tinzaparin)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Low Anti-Factor Xa Level Predicts 90-Day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis A Pooled Analysis of Eight Clinical Trials

Christopher J. Pannucci et al.

Summary: This study confirms the association between inadequate enoxaparin dosing and VTE recurrence in surgical patients, and identifies anticoagulant dose adequacy as a new target for improvement measures.

ANNALS OF SURGERY (2022)

Article Hematology

Preventing VTE following total hip and knee arthroplasty: Is prediction the future?

Banne Nemeth et al.

Summary: VTE is a common complication following THA and TKA, despite available guidelines for prophylaxis, approximately 1.5% of patients still develop symptomatic VTE. This paper discusses an individualized approach to optimize the balance between VTE and bleeding risks by stratifying patients according to their risk levels.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Hematology

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

Gary H. Lyman et al.

Summary: These evidence-based guidelines aim to support decision-making on the prevention and treatment of VTE in cancer patients, covering mechanical and pharmacological prophylaxis, as well as recommendations for initial, short-term, and long-term treatment based on patient risk and treatment circumstances. Recommendations vary depending on patient risk level and treatment situation.

BLOOD ADVANCES (2021)

Review Medicine, General & Internal

Venous thromboembolism

Faizan Khan et al.

Summary: Venous thromboembolism is a chronic illness affecting millions of people globally each year. Diagnosis involves a combination of clinical scoring, D-dimer testing, and imaging. Treatment typically consists of direct oral anticoagulants, with indefinite anticoagulant therapy recommended for high-risk patients. Ongoing research focuses on improving diagnostic strategies and developing safer anticoagulants.

LANCET (2021)

Review Hematology

Extended thromboprophylaxis for medically ill patients with cancer: a systemic review and meta-analysis

Soravis Osataphan et al.

Summary: This study evaluated the efficacy of extended thromboprophylaxis in 3655 medically ill patients with cancer, finding that the extended-duration group had a significantly higher risk of bleeding, but the rates of venous thromboembolic events were similar to the standard-duration group.

BLOOD ADVANCES (2021)

Article Surgery

Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?

Semiramis L. Carbajal-Mamani et al.

Summary: Extended thromboprophylaxis did not significantly increase the risk of venous thromboembolism in obese patients undergoing robotic surgery for endometrial cancer, with similar rates of perioperative complications and readmissions between the extended and non-extended prophylaxis groups.

JOURNAL OF ROBOTIC SURGERY (2021)

Article Obstetrics & Gynecology

Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer

Nobutaka Tasaka et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2020)

Article Hematology

Inpatient prophylaxis in cancer patients: where is the evidence?

Rushad Patell et al.

THROMBOSIS RESEARCH (2020)

Article Hematology

A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn score

Lucy A. Norris et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Article Medicine, General & Internal

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

A. A. Khorana et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Hematology

Venous thromboembolism in epithelial ovarian cancer. A prospective cohort study

Henriette Strom Kahr et al.

THROMBOSIS RESEARCH (2019)

Article Medicine, General & Internal

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Marc Carrier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Obstetrics & Gynecology

Thromboprophylaxis in gynecologic cancer surgery: Is extended prophylaxis with low molecular weight heparin justified?

Pablo Marques de Marino et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2018)

Review Hematology

The Role of Tinzaparin in Oncology

Evangelos P. Dimakakos et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)

Review Oncology

Prevention of venous thromboembolism in gynecologic oncology surgery

Emma L. Barber et al.

GYNECOLOGIC ONCOLOGY (2017)

Review Oncology

Cancer and Venous Thromboembolic Disease: A Review

Eoin Donnellan et al.

ONCOLOGIST (2017)

Editorial Material Obstetrics & Gynecology

Staging classification for cancer of the ovary, fallopian tube, and peritoneum

Jaime Prat

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2014)

Article Obstetrics & Gynecology

The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas

David G. Mutch

GYNECOLOGIC ONCOLOGY (2009)

Article Medicine, General & Internal

Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study

Sian Sweetland et al.

BMJ-BRITISH MEDICAL JOURNAL (2009)

Article Medicine, General & Internal

Thrombosis risk assessment as a guide to quality patient care

JA Caprini

DM DISEASE-A-MONTH (2005)

Article Medicine, General & Internal

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

D Bergqvist et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)